Notice Information
Notice Title
The Guardant360 assay kits
Notice Description
The Guardant360 assay kits are required to deliver the Trust's partnership agreement with Guardant Health. This is the only kit that can be used to deliver this and is included in the contract requirements with Guardant.
Lot Information
Lot 1
The G360 assay designed by Guardant Health is run using Guardant's proprietary sequencing reagents and bioinformatics pipeline and as such an alternative sequencing assay cannot be used. This is direct award to Guardant Health due to designed kits which are needed to run the Guardant assay.
Procurement Information
There is only one supplier i.e. Guardant, we have to use their kit to run the Guardant assay, there is no alternative. We have formed a partnership with Guardant to provide this service. Guardant360 CDx utilizes circulating tumour DNA (ctDNA) from plasma of peripheral whole blood collected in Streck Cell-Free DNA Blood Collection Tubes (BCTs). Guardant360(r) CDx is a qualitative custom designed next generation sequencing-based in vitro diagnostic device that uses targeted high throughput hybridization-based capture technology for detection of single nucleotide variants (SNVs), insertions and deletions (indels) in 55 genes, copy number amplifications (CNAs) in two (2) genes, and fusions in four (4) genes.
Notice Details
Publication & Lifecycle
- Open Contracting ID
- ocds-h6vhtk-03444c
- Publication Source
- Find A Tender Service
- Latest Notice
- https://www.find-tender.service.gov.uk/Notice/015783-2022
- Current Stage
- Award
- All Stages
- Award
Procurement Classification
- Notice Type
- Award Notice
- Procurement Type
- Standard
- Procurement Category
- Goods
- Procurement Method
- Limited
- Procurement Method Details
- Negotiated without publication of a contract notice
- Tender Suitability
- Not specified
- Awardee Scale
- Large
Common Procurement Vocabulary (CPV)
- CPV Divisions
33 - Medical equipments, pharmaceuticals and personal care products
-
- CPV Codes
33910000 - Pathology dissection instruments and supplies
Notice Value(s)
- Tender Value
- Not specified
- Lots Value
- Not specified
- Awards Value
- Not specified
- Contracts Value
- £1,638,336 £1M-£10M
Notice Dates
- Publication Date
- 8 Jun 20223 years ago
- Submission Deadline
- Not specified
- Future Notice Date
- Not specified
- Award Date
- 14 Oct 20214 years ago
- Contract Period
- Not specified - Not specified
- Recurrence
- Not specified
Notice Status
- Tender Status
- Complete
- Lots Status
- Not Specified
- Awards Status
- Active
- Contracts Status
- Active
Buyer & Supplier
Contracting Authority (Buyer)
- Main Buyer
- THE ROYAL MARSDEN NHS FOUNDATION TRUST
- Contact Name
- chelwest.tenders@nhs.net
- Contact Email
- chelwest.tenders@nhs.net
- Contact Phone
- Not specified
Buyer Location
- Locality
- LONDON
- Postcode
- SW10 0XD
- Post Town
- South West London
- Country
- England
-
- Major Region (ITL 1)
- TLI London
- Basic Region (ITL 2)
- TLI3 Inner London - West
- Small Region (ITL 3)
- TLI33 Kensington & Chelsea and Hammersmith & Fulham
- Delivery Location
- Not specified
-
- Local Authority
- Hammersmith and Fulham
- Electoral Ward
- Sands End
- Westminster Constituency
- Chelsea and Fulham
Further Information
Open Contracting Data Standard (OCDS)
View full OCDS Record for this contracting process
The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.
{
"tag": [
"compiled"
],
"id": "ocds-h6vhtk-03444c-2022-06-08T14:30:18+01:00",
"date": "2022-06-08T14:30:18+01:00",
"ocid": "ocds-h6vhtk-03444c",
"initiationType": "tender",
"tender": {
"id": "ocds-h6vhtk-03444c",
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"title": "The Guardant360 assay kits",
"status": "complete",
"classification": {
"scheme": "CPV",
"id": "33910000",
"description": "Pathology dissection instruments and supplies"
},
"mainProcurementCategory": "goods",
"description": "The Guardant360 assay kits are required to deliver the Trust's partnership agreement with Guardant Health. This is the only kit that can be used to deliver this and is included in the contract requirements with Guardant.",
"lots": [
{
"id": "1",
"description": "The G360 assay designed by Guardant Health is run using Guardant's proprietary sequencing reagents and bioinformatics pipeline and as such an alternative sequencing assay cannot be used. This is direct award to Guardant Health due to designed kits which are needed to run the Guardant assay.",
"awardCriteria": {
"criteria": [
{
"type": "price"
}
]
},
"hasOptions": false
}
],
"items": [
{
"id": "1",
"deliveryAddresses": [
{
"region": "UK"
}
],
"relatedLot": "1"
}
],
"procurementMethod": "limited",
"procurementMethodDetails": "Negotiated without publication of a contract notice",
"coveredBy": [
"GPA"
],
"procurementMethodRationaleClassifications": [
{
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
"id": "D_ARTISTIC",
"description": "The works, supplies or services can be provided only by a particular economic operator due to procurement aiming at the creation or acquisition of a unique work of art or artistic performance"
}
],
"procurementMethodRationale": "There is only one supplier i.e. Guardant, we have to use their kit to run the Guardant assay, there is no alternative. We have formed a partnership with Guardant to provide this service. Guardant360 CDx utilizes circulating tumour DNA (ctDNA) from plasma of peripheral whole blood collected in Streck Cell-Free DNA Blood Collection Tubes (BCTs). Guardant360(r) CDx is a qualitative custom designed next generation sequencing-based in vitro diagnostic device that uses targeted high throughput hybridization-based capture technology for detection of single nucleotide variants (SNVs), insertions and deletions (indels) in 55 genes, copy number amplifications (CNAs) in two (2) genes, and fusions in four (4) genes."
},
"awards": [
{
"id": "015783-2022-1",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-54968",
"name": "Guardant Health"
}
]
}
],
"parties": [
{
"id": "GB-FTS-2920",
"name": "The Royal Marsden NHS Foundation Trust",
"identifier": {
"legalName": "The Royal Marsden NHS Foundation Trust"
},
"address": {
"streetAddress": "Unit G3, Harbour Yard, Chelsea Harbour",
"locality": "London",
"region": "UKI33",
"postalCode": "SW10 0XD",
"countryName": "United Kingdom"
},
"contactPoint": {
"name": "chelwest.tenders@nhs.net",
"email": "chelwest.tenders@nhs.net"
},
"roles": [
"buyer",
"reviewBody",
"reviewContactPoint"
],
"details": {
"url": "https://www.royalmarsden.nhs.uk",
"buyerProfile": "https://www.royalmarsden.nhs.uk",
"classifications": [
{
"scheme": "TED_CA_TYPE",
"id": "BODY_PUBLIC",
"description": "Body governed by public law"
},
{
"scheme": "COFOG",
"id": "07",
"description": "Health"
}
]
},
"additionalContactPoints": [
{
"email": "chelwest.tenders@nhs.net"
}
]
},
{
"id": "GB-FTS-54968",
"name": "Guardant Health",
"identifier": {
"legalName": "Guardant Health"
},
"address": {
"streetAddress": "505 Penobscot Drive Redwood City CA 94063 United States",
"locality": "Redwood City",
"region": "US",
"postalCode": "CA 94063",
"countryName": "United States"
},
"roles": [
"supplier"
],
"details": {
"scale": "large"
}
},
{
"id": "GB-FTS-497",
"name": "The High Court",
"identifier": {
"legalName": "The High Court"
},
"address": {
"streetAddress": "Strand",
"locality": "London",
"postalCode": "WC2A 2LL",
"countryName": "United Kingdom"
},
"contactPoint": {
"email": "generaloffice@administrativecourtoffice.justice.gov.uk"
},
"roles": [
"mediationBody"
],
"details": {
"url": "https://www.gov.uk/courts-tribunals"
}
}
],
"buyer": {
"id": "GB-FTS-2920",
"name": "The Royal Marsden NHS Foundation Trust"
},
"contracts": [
{
"id": "015783-2022-1",
"awardID": "015783-2022-1",
"status": "active",
"value": {
"amount": 1638336,
"currency": "GBP"
},
"dateSigned": "2021-10-15T00:00:00+01:00"
}
],
"language": "en"
}